Surgery versus intra-arterial therapy for neuroendocrine liver metastasis: a multicenter international analysis. (Q53151516)

11 May 2018

title

Surgery versus intra-arterial therapy for neuroendocrine liver metastasis: a multicenter international analysis. (English)

1 reference

11 May 2018

1 reference

24

Timothy M Pawlik

1 reference

11 May 2018

Richard D Schulick

15

object named as

Richard D Schulick

1 reference

11 May 2018

Luca Antonio Aldrighetti

21

object named as

Luca Aldrighetti

1 reference

11 May 2018

author name string

Skye C Mayo

1

1 reference

11 May 2018

Mechteld C de Jong

2

1 reference

11 May 2018

Mark Bloomston

3

1 reference

11 May 2018

Carlo Pulitano

4

1 reference

11 May 2018

Bryan M Clary

5

1 reference

11 May 2018

Srinevas K Reddy

6

1 reference

11 May 2018

T Clark Gamblin

7

1 reference

11 May 2018

Scott A Celinski

8

1 reference

11 May 2018

David A Kooby

9

1 reference

11 May 2018

Charles A Staley

10

1 reference

11 May 2018

Jayme B Stokes

11

1 reference

11 May 2018

Carrie K Chu

12

1 reference

11 May 2018

David Arrese

13

1 reference

11 May 2018

Alessandro Ferrero

14

1 reference

11 May 2018

Michael A Choti

16

1 reference

11 May 2018

Jean-Francois H Geschwind

17

1 reference

11 May 2018

Jennifer Strub

18

1 reference

11 May 2018

Todd W Bauer

19

1 reference

11 May 2018

Reid B Adams

20

1 reference

11 May 2018

Gilles Mentha

22

1 reference

11 May 2018

Lorenzo Capussotti

23

1 reference

11 May 2018

publication date

17 June 2011

1 reference

11 May 2018

Annals of Surgical Oncology

published in

1 reference

11 May 2018

volume

18

1 reference

11 May 2018

issue

13

1 reference

11 May 2018

page(s)

3657-3665

1 reference

11 May 2018

https://scigraph.springernature.com/pub.10.1245/s10434-011-1832-y

exact match

0 references

cites work

A 5-decade analysis of 13,715 carcinoid tumors

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1832-Y

Hepatic neuroendocrine metastases: does intervention alter outcomes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1832-Y

Long-term survival after resection for primary hepatic carcinoid tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1832-Y

Surgery as primary treatment in patients with liver metastases from carcinoid tumors: a retrospective, unicentric study over 13 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1832-Y

Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1832-Y

Chemotherapy for gastro-enteropancreatic endocrine tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1832-Y

Clinical and imaging follow-up after exhaustive liver resection of endocrine metastases: a 15-year monocentric experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1832-Y

Surgical management of hepatic neuroendocrine tumor metastasis: results from an international multi-institutional analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1832-Y

Long-term outcome after chemoembolization and embolization of hepatic metastatic lesions from neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1832-Y

Functional MRI evaluation of tumor response in patients with neuroendocrine hepatic metastasis treated with transcatheter arterial chemoembolization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1832-Y

Transcatheter arterial chemoembolization: current technique and future promise.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1832-Y

Factors predicting response and survival after yttrium-90 radioembolization of unresectable neuroendocrine tumor liver metastases: a critical appraisal of 48 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1832-Y

Hepatic artery embolization and chemoembolization for treatment of patients with metastatic carcinoid tumors: the M.D. Anderson experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1832-Y

Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1832-Y

Nomenclature of hepatic anatomy and resections: a review of the Brisbane 2000 system

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1832-Y

RECIST revisited: a review of validation studies on tumour assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1832-Y

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1832-Y

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1832-Y

The central role of the propensity score in observational studies for causal effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1832-Y

Estimating causal effects from large data sets using propensity scores

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1832-Y

The design versus the analysis of observational studies for causal effects: parallels with the design of randomized trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1832-Y

Colorectal liver metastases: recurrence and survival following hepatic resection, radiofrequency ablation, and combined resection-radiofrequency ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1832-Y

Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1832-Y

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1832-Y

Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma: are response evaluation criteria in solid tumors reliable?

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1832-Y

10.1245/S10434-011-1832-Y

21 January 2018

Identifiers

DOI

1 reference

11 May 2018

Dimensions Publication ID

1010677260

0 references

1 reference

11 May 2018